SCHEMBL30686187

SCHEMBL30686187

COC1C(=O)OC(=O)C1(OC)C(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.38
▸ KMT2A Q03164 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ TSHR P16473 2/20 0.35
▸ CES2 O00748 1/20 0.35
▸ CES1 P23141 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ HTT P42858 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ ELANE P08246 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7415226 0.71 F2 (0.37) LMNAKMT2ARAB9AMAPTNPC1
SCHEMBL1751899 0.71 F2 (0.37) LMNAKMT2ARAB9AMAPTNPC1
SCHEMBL7410693 0.71 F2 (0.37) LMNAKMT2ARAB9AMAPTNPC1
SCHEMBL31653943 0.64 MAOA (0.35) LMNAKMT2ARAB9AMAPTNPC1
SCHEMBL1751898 0.62 CES1 (0.41) LMNAKMT2AMAPTMAPK1SMN1; SMN2
SCHEMBL8966023 0.62 CES1 (0.41) LMNAKMT2AMAPTMAPK1SMN1; SMN2
SCHEMBL10384827 0.61 ALDH1A1 (0.43) LMNAKMT2ARAB9AMAPTNPC1
SCHEMBL9767838 0.59 CES1 (0.46) LMNAKMT2AMAPTMAPK1SMN1; SMN2
SCHEMBL9767756 0.59 CES1 (0.46) LMNAKMT2AMAPTMAPK1SMN1; SMN2
SCHEMBL9767764 0.59 CES1 (0.46) LMNAKMT2AMAPTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115322157-B Letermopevir intermediate compound, preparation method and application thereof 浙江车头制药股份有限公司 2023-12-05 — — CN disclosed
Send feedback